Interview with Peter Rothschild regarding results of Interim report Q2 2013

NewsAugust 26, 2013

Peter Rothschild, CEO of BioGaia, summarizes the second quarter of 2013 and answers to questions regarding the new deal with Nestlé, expectations on the the new distribution agreements in China and South Korea, what it means to be classified as an “orphan drug” by the FDA and also the regulatory progress in Brazil.

See the interview on the BioGaia YouTube-channel

Upcoming events

January 5, 2025

Invitation to media and analyst briefing for BioGaia

Elementum nisi pharetra faucibus cras. At massa pretium sodales nunc arcu ullamcorper semper.
January 15, 2025

BioGaia AB: Year-end report January – December 2023

Elementum nisi pharetra faucibus cras. At massa pretium sodales nunc arcu ullamcorper semper.

Subscribe to our press releases

Vulputate proin pellentesque ut tincidunt elementum volutpat urna dolor sit amet.

Subscribe